PROGRESS OF DEVELOPMENT
Disclosuring of information after Phase 3
| Drug | Dosage Form | Property | Indication | Status (Region) |
|---|---|---|---|---|
| Difluprednate | Eye drop | Corticosteroids | inflammation associated with ocular surgery, Uveitis | Approved (Russia) |
| SJP-0132 | Eye drop | Novel mechanism of action | Dry eye | P3（Japan） |
| SJP-0135 | Eye drop | Fixed combination | Glaucoma | P3（Japan） |
| SJP-0008 | Oral tablet | Novel mechanism of action | Central Retinal Artery Occlusion (CRAO) | P3（Japan） |